These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 36550798)

  • 21. Wernicke-like encephalopathy during classic maple syrup urine disease decompensation.
    Manara R; Del Rizzo M; Burlina AP; Bordugo A; Citton V; Rodriguez-Pombo P; Ugarte M; Burlina AB
    J Inherit Metab Dis; 2012 May; 35(3):413-7. PubMed ID: 22350544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural white matter changes in adolescents and young adults with maple syrup urine disease.
    Klee D; Thimm E; Wittsack HJ; Schubert D; Primke R; Pentang G; Schaper J; Mödder U; Antoch A; Wendel U; Cohnen M
    J Inherit Metab Dis; 2013 Nov; 36(6):945-53. PubMed ID: 23355088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neonatal maple syrup urine disease in China: two novel mutations in the BCKDHB gene and literature review.
    Jiang HH; Guo Y; Shen X; Wang Y; Dai TT; Rong H; Cheng R; Zhao F
    J Pediatr Endocrinol Metab; 2021 Sep; 34(9):1147-1156. PubMed ID: 34187135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Maple Syrup Urine Disease in a newborn infant].
    Mazur A; Sykut-Cegielska J; Ciebiera M; Trzeciak J; Taybert J; Kowalik A; Ołtarzewski M
    Med Wieku Rozwoj; 2007; 11(1):65-8. PubMed ID: 17965467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intermittent neurological symptoms in a girl with a maple syrup urine disease (MSUD) variant.
    Holmgren G; Brundin A; Gustavson KH; Sjögren S; Kleijer WJ; Niermeijer MF
    Neuropediatrics; 1980 Nov; 11(4):377-83. PubMed ID: 7207707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Implications of Maple Syrup Urine Disease in Newborns.
    Harris-Haman P; Brown L; Massey S; Ramamoorthy S
    Nurs Womens Health; 2017; 21(3):196-206. PubMed ID: 28599741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dysmyelination in the brain of adolescents and young adults with maple syrup urine disease.
    Schönberger S; Schweiger B; Schwahn B; Schwarz M; Wendel U
    Mol Genet Metab; 2004 May; 82(1):69-75. PubMed ID: 15110325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of acute metabolic decompensation in children with maple syrup urine disease at the emergency department.
    Yıldız Y; Akcan Yıldız L; Dursun A; Tokatlı A; Coşkun T; Tekşam Ö; Sivri HS
    Eur J Pediatr; 2020 Jul; 179(7):1107-1114. PubMed ID: 32048023
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [GENETIC AND METABOLIC URGENCIES IN THE NEONATAL INTENSIVE CARE UNIT: MAPLE SYRUP URINE DISEASE].
    Páez Rojas PL; Suarez Obando F
    Nutr Hosp; 2015 Jul; 32(1):420-5. PubMed ID: 26262748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Maple syrup urine disease: further evidence that newborn screening may fail to identify variant forms.
    Puckett RL; Lorey F; Rinaldo P; Lipson MH; Matern D; Sowa ME; Levine S; Chang R; Wang RY; Abdenur JE
    Mol Genet Metab; 2010 Jun; 100(2):136-42. PubMed ID: 20307994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dual mechanism of brain injury and novel treatment strategy in maple syrup urine disease.
    Zinnanti WJ; Lazovic J; Griffin K; Skvorak KJ; Paul HS; Homanics GE; Bewley MC; Cheng KC; Lanoue KF; Flanagan JM
    Brain; 2009 Apr; 132(Pt 4):903-18. PubMed ID: 19293241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic tools of early brain disturbances in an asymptomatic neonate with maple syrup urine disease.
    Terek D; Koroglu O; Yalaz M; Gokben S; Calli C; Coker M; Kultursay N
    Neuropediatrics; 2013 Aug; 44(4):208-12. PubMed ID: 23341096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maple Syrup Urine Disease Complicated with Kyphoscoliosis and Myelopathy.
    Hou JW
    Pediatr Neonatol; 2016 Oct; 57(5):431-435. PubMed ID: 24486081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Computed tomography findings in maple syrup urine disease.
    Ong LC; Khoo TB; Zulfiqar A; Zarida H; Ruzana A
    Singapore Med J; 1998 Aug; 39(8):370-2. PubMed ID: 9844500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clues and challenges in the diagnosis of intermittent maple syrup urine disease.
    Pode-Shakked N; Korman SH; Pode-Shakked B; Landau Y; Kneller K; Abraham S; Shaag A; Ulanovsky I; Daas S; Saraf-Levy T; Reznik-Wolf H; Vivante A; Pras E; Almashanu S; Anikster Y
    Eur J Med Genet; 2020 Jun; 63(6):103901. PubMed ID: 32151765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The electroencephalogram in neonatal maple syrup urine disease: a case report.
    Agadi S; Sutton VR; Quach MM; Riviello JJ
    Clin EEG Neurosci; 2012 Jan; 43(1):64-7. PubMed ID: 22423553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maple syrup urine disease: magnetic resonance imaging findings in three patients.
    Allahwala A; Ahmed S; Afroze B
    J Pak Med Assoc; 2021 Apr; 71(4):1309-1313. PubMed ID: 34125801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diffusion magnetic resonance imaging in intermediate form of maple syrup urine disease.
    Sener RN
    J Neuroimaging; 2002 Oct; 12(4):368-70. PubMed ID: 12380485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term metabolic follow-up and clinical outcome of 35 patients with maple syrup urine disease.
    Abi-Wardé MT; Roda C; Arnoux JB; Servais A; Habarou F; Brassier A; Pontoizeau C; Barbier V; Bayart M; Leboeuf V; Chadefaux-Vekemans B; Dubois S; Assoun M; Belloche C; Alili JM; Husson MC; Lesage F; Dupic L; Theuil B; Ottolenghi C; de Lonlay P
    J Inherit Metab Dis; 2017 Nov; 40(6):783-792. PubMed ID: 28905140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Imaging in neonatal maple syrup urine disease.
    Jain P; Sharma S; Sankhyan N; Gupta N; Kabra M; Gulati S
    Indian J Pediatr; 2013 Jan; 80(1):87-8. PubMed ID: 22865353
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.